{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,4]],"date-time":"2026-11-04T01:37:21Z","timestamp":1793756241795,"version":"4.6.1"},"reference-count":77,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2026,9,9]],"date-time":"2026-09-09T00:00:00Z","timestamp":1788912000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Microbiol."],"abstract":"<jats:p>\n                    <jats:italic>Helicobacter pylori<\/jats:italic>\n                    (\n                    <jats:italic>H. pylori<\/jats:italic>\n                    ) is a human gastric pathogen that colonizes the stomach by adapting to acidic pH, penetrating the gastric mucus layer, adhering to epithelial and mucosal receptors, and delivering virulence factors that promote inflammation and immune evasion. Antibiotic-based regimens have markedly reduced the burden of\n                    <jats:italic>H. pylori<\/jats:italic>\n                    -associated disease; however, increasing antimicrobial resistance, treatment failure, recurrence, and disruption of the gut microbiota remain important clinical challenges. Future therapeutic strategies should therefore combine bacterial control with modulation of the gastric environment that sustains chronic infection and impaired host responses. Chitosan-based micro- and nanoparticles are promising delivery systems for drugs and biologically active compounds because of their biodegradability, cationic surface charge, and mucoadhesive properties. This Mini Review summarizes chitosan-based formulations proposed for the delivery of antibiotics, plant-derived antimicrobial compounds, and antimicrobial peptides, as well as systems targeting\n                    <jats:italic>H. pylori<\/jats:italic>\n                    adhesins, bacterial biofilm, or urease activity. We also discuss an experimental concept in which the immunomodulatory vaccine strain\n                    <jats:italic>Mycobacterium bovis<\/jats:italic>\n                    Bacillus Calmette-Guerin (BCG) is encapsulated in chitosan micro- or nanoparticles for gastric and\/or intestinal delivery. Available\n                    <jats:italic>in vitro<\/jats:italic>\n                    and\n                    <jats:italic>in vivo<\/jats:italic>\n                    evidence suggests that chitosan-based systems may increase local exposure to active components, support mucosal immune responses, and potentially facilitate epithelial repair. Nevertheless, most data remain preclinical, and clinical efficacy in humans has not been demonstrated. The review highlights the need for broader independent validation, careful biosafety assessment, and standardized formulation parameters before these approaches can be considered for translation.\n                  <\/jats:p>","DOI":"10.3389\/fmicb.2026.1937380","type":"journal-article","created":{"date-parts":[[2026,9,9]],"date-time":"2026-09-09T15:17:22Z","timestamp":1788967042000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":1,"title":["New concepts of chitosan-based mucosal formulations for supporting control of the gastric pathogen Helicobacter pylori"],"prefix":"10.3389","volume":"17","author":[{"given":"Patrycja","family":"Jaroniek","sequence":"first","affiliation":[{"name":"Department of Immunology and Infectious Biology, Institute of Microbiology, Biotechnology and Immunology, Faculty of Biology and Environmental Protection, University of Lodz","place":["Lodz, Poland"]},{"name":"BioMedChem Doctoral School of the University of Lodz and Lodz Institutes of the Polish Academy of Sciences, University of Lodz","place":["Lodz, Poland"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria","family":"Po\u0142omska","sequence":"additional","affiliation":[{"name":"Department of Immunology and Infectious Biology, Institute of Microbiology, Biotechnology and Immunology, Faculty of Biology and Environmental Protection, University of Lodz","place":["Lodz, Poland"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Magdalena","family":"Chmiela","sequence":"additional","affiliation":[{"name":"Department of Immunology and Infectious Biology, Institute of Microbiology, Biotechnology and Immunology, Faculty of Biology and Environmental Protection, University of Lodz","place":["Lodz, Poland"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Weronika","family":"Gonciarz","sequence":"additional","affiliation":[{"name":"Department of Immunology and Infectious Biology, Institute of Microbiology, Biotechnology and Immunology, Faculty of Biology and Environmental Protection, University of Lodz","place":["Lodz, Poland"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2026,9,9]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"21693","DOI":"10.1038\/s41598-024-65762-2","article-title":"Anti-Helicobacter pylori activity of nanocomposites from chitosan\/broccoli mucilage\/selenium nanoparticles","volume":"14","author":"Aborabu","year":"2024","journal-title":"Sci. Rep."},{"key":"B2","doi-asserted-by":"publisher","first-page":"1686","DOI":"10.3390\/pharmaceutics13101686","article-title":"Chitosan nanoparticles at the biological interface: implications for drug delivery","volume":"13","author":"Aibani","year":"2021","journal-title":"Pharmaceutics"},{"key":"B3","doi-asserted-by":"publisher","first-page":"1592977","DOI":"10.3389\/fcimb.2025.1592977","article-title":"The impact of Helicobacter pylori infection and eradication therapies on gut microbiota: a systematic review of microbial dysbiosis and its implications in gastric carcinogenesis","volume":"15","author":"Albush","year":"2025","journal-title":"Front. Cell. Infect. Microbiol."},{"key":"B4","doi-asserted-by":"publisher","first-page":"46","DOI":"10.1186\/s40643-026-01031-6","article-title":"Chitosan-mediated nano-bioprocessing of Acacia seyal seed extract for enhanced antineoplastic, anti-Helicobacter pylori and antioxidant performance","volume":"13","author":"Al-Rajhi","year":"2026","journal-title":"Biores. Bioprocess"},{"key":"B5","doi-asserted-by":"publisher","first-page":"132","DOI":"10.3390\/pharmaceutics17010132","article-title":"Chitosan nanoparticles for enhanced immune response and delivery of multi-epitope H. pylori vaccines","volume":"17","author":"Amaral","year":"2025","journal-title":"Pharmaceutics"},{"key":"B6","doi-asserted-by":"publisher","first-page":"677","DOI":"10.3390\/toxins11110677","article-title":"Helicobacter pylori virulence factors exploiting gastric colonization and its pathogenicity","volume":"11","author":"Ansari","year":"2019","journal-title":"Toxins."},{"key":"B7","doi-asserted-by":"publisher","first-page":"3256","DOI":"10.3390\/polym13193256","article-title":"Chitosan: an overview of its properties and applications","volume":"13","author":"Aranaz","year":"2021","journal-title":"Polymers."},{"key":"B8","doi-asserted-by":"publisher","first-page":"418","DOI":"10.1016\/j.ijbiomac.2022.10.265","article-title":"Antibacterial and antibiofilm activity of mannose-modified chitosan\/PMLA nanoparticles against multidrug-resistant Helicobacter pylori","volume":"223","author":"Arif","year":"2022","journal-title":"Int. J. Biol. Macromol."},{"key":"B9","doi-asserted-by":"publisher","first-page":"673","DOI":"10.3797\/scipharm.1011-05","article-title":"Amoxicillin-loaded chitosan-alginate polyelectrolyte complex nanoparticles as mucopenetrating delivery system for H. pylori","volume":"79","author":"Arora","year":"2011","journal-title":"Sci. Pharm"},{"key":"B10","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1016\/j.chom.2017.12.010","article-title":"BCG vaccination protects against experimental viral infection in humans through the induction of cytokines associated with trained immunity","volume":"23","author":"Arts","year":"2018","journal-title":"Cell Host Microbe"},{"key":"B11","doi-asserted-by":"publisher","first-page":"e110","DOI":"10.1371\/journal.ppat.0020110","article-title":"SabA is the H. pylori hemagglutinin and is polymorphic in binding to sialylated glycans","volume":"2","author":"Aspholm","year":"2006","journal-title":"PLoS Pathog"},{"key":"B12","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1186\/1478-811X-9-28","article-title":"Molecular mechanisms of gastric epithelial cell adhesion and injection of CagA by Helicobacter pylori","volume":"9","author":"Backert","year":"2011","journal-title":"Cell Commun. Signal."},{"key":"B13","doi-asserted-by":"publisher","first-page":"16923","DOI":"10.1073\/pnas.0404817101","article-title":"Metastability of Helicobacter pylori bab adhesin genes and dynamics in Lewis b antigen binding","volume":"101","author":"B\u00e4ckstr\u00f6m","year":"2004","journal-title":"Proc. Natl. Acad. Sci. U.S.A"},{"key":"B14","doi-asserted-by":"publisher","first-page":"27","DOI":"10.3390\/cells10010027","article-title":"Helicobacter pylori virulence factors-mechanisms of bacterial pathogenicity in the gastric microenvironment","volume":"10","author":"Baj","year":"2021","journal-title":"Cells"},{"key":"B15","doi-asserted-by":"publisher","first-page":"203","DOI":"10.1080\/02652048.2017.1316325","article-title":"BCG-loaded chitosan microparticles: interaction with macrophages and preliminary in vivo studies","volume":"34","author":"Caetano","year":"2017","journal-title":"J. Microencapsul."},{"key":"B16","doi-asserted-by":"publisher","first-page":"11411","DOI":"10.3748\/wjg.v21.i40.11411","article-title":"Tight junction disruption: Helicobacter pylori and dysregulation of the gastric mucosal barrier","volume":"21","author":"Caron","year":"2015","journal-title":"World J. Gastroenterol."},{"key":"B17","doi-asserted-by":"publisher","first-page":"127692","DOI":"10.1016\/j.vaccine.2025.127692","article-title":"Chitosan-based oral DNA vaccine elicits mucosal immunity and reduces Helicobacter pylori colonization in mice","volume":"64","author":"Chan","year":"2025","journal-title":"Vaccine"},{"key":"B18","doi-asserted-by":"publisher","first-page":"542","DOI":"10.3390\/md18110542","article-title":"Chitosan inhibits H. pylori growth and urease production and prevents infection of gastric carcinoma cells","volume":"18","author":"Chang","year":"2020","journal-title":"Mar. Drugs"},{"key":"B19","doi-asserted-by":"publisher","first-page":"1211","DOI":"10.3390\/pharmaceutics12121211","article-title":"Design of mucoadhesive nanostructured polyelectrolyte complexes based on chitosan and hypromellose phthalate for metronidazole delivery intended to the treatment of Helicobacter pylori infections","volume":"12","author":"Chaves de Souza","year":"2020","journal-title":"Pharmaceutics"},{"key":"B20","doi-asserted-by":"publisher","first-page":"106","DOI":"10.1186\/s12967-023-03944-8","article-title":"BCG-induced trained immunity: history, mechanisms and potential applications","volume":"21","author":"Chen","year":"2023","journal-title":"J. Transl. Med."},{"key":"B21","doi-asserted-by":"publisher","first-page":"5156","DOI":"10.3390\/md13085156","article-title":"Chitosan: an update on potential biomedical and pharmaceutical applications","volume":"13","author":"Cheung","year":"2015","journal-title":"Mar. Drugs"},{"key":"B22","doi-asserted-by":"publisher","first-page":"1730","DOI":"10.14309\/ajg.0000000000002968","article-title":"ACG clinical guideline: treatment of Helicobacter pylori infection","volume":"119","author":"Chey","year":"2024","journal-title":"Am. J. Gastroenterol."},{"key":"B23","doi-asserted-by":"publisher","first-page":"78","DOI":"10.1186\/s12929-024-01068-9","article-title":"Targeted nanotherapeutics for the treatment of Helicobacter pylori infection","volume":"31","author":"Chitas","year":"2024","journal-title":"J. Biomed. Sci."},{"key":"B24","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1136\/gut.40.1.20","article-title":"Role of Helicobacter pylori surface structures in bacterial interaction with macrophages","volume":"40","author":"Chmiela","year":"1997","journal-title":"Gut"},{"key":"B25","doi-asserted-by":"publisher","first-page":"e12638","DOI":"10.1111\/hel.12638","article-title":"Review: pathogenesis of Helicobacter pylori infection","volume":"24","author":"Chmiela","year":"2019","journal-title":"Helicobacter"},{"key":"B26","doi-asserted-by":"publisher","first-page":"9882","DOI":"10.3748\/wjg.v20.i29.9882","article-title":"Structural modifications of Helicobacter pylori lipopolysaccharide: an idea for how to live in peace","volume":"20","author":"Chmiela","year":"2014","journal-title":"World J. Gastroenterol."},{"key":"B27","doi-asserted-by":"publisher","first-page":"2438735","DOI":"10.1080\/21505594.2024.2438735","article-title":"Pathogenicity and virulence of Helicobacter pylori","volume":"16","author":"Clyne","year":"2025","journal-title":"virulence"},{"key":"B28","doi-asserted-by":"publisher","first-page":"1260","DOI":"10.3390\/antibiotics12081260","article-title":"Biofilm of Helicobacter pylori: life cycle, features, and treatment options","volume":"12","author":"Elshenawi","year":"2023","journal-title":"Antibiotics"},{"key":"B29","doi-asserted-by":"publisher","first-page":"1333","DOI":"10.3390\/vaccines11081333","article-title":"Efficiency of chitosan nanocarriers in vaccinology for mucosal immunization","volume":"11","author":"Gaglio","year":"2023","journal-title":"Vaccines"},{"key":"B30","doi-asserted-by":"publisher","first-page":"62","DOI":"10.1186\/s12929-025-01161-7","article-title":"Chitosan-based formulations for therapeutic applications. A recent overview","volume":"32","author":"Gonciarz","year":"2025","journal-title":"J. Biomed. Sci"},{"key":"B31","doi-asserted-by":"publisher","first-page":"4747","DOI":"10.1038\/s41598-024-55353-6","article-title":"Spray-dried pH-sensitive chitosan microparticles loaded with Mycobacterium bovis BCG intended for supporting treatment of Helicobacter pylori infection","volume":"14","author":"Gonciarz","year":"","journal-title":"Sci. Rep."},{"key":"B32","doi-asserted-by":"publisher","first-page":"1771052","DOI":"10.3389\/fimmu.2026.1771052","article-title":"Upregulation of innate and adaptive immune mechanisms facilitating prevention of gastric Helicobacter pylori infection in guinea pigs by per os administration of chitosan microparticles loaded with Mycobacterium bovis BCG","volume":"17","author":"Gonciarz","year":"","journal-title":"Front. Immunol."},{"key":"B33","doi-asserted-by":"publisher","first-page":"3107","DOI":"10.1038\/s41598-023-30250-6","article-title":"Mycobacterium bovis BCG increases the selected determinants of monocyte\/macrophage activity, which were diminished in response to the gastric pathogen Helicobacter pylori","volume":"13","author":"Gonciarz","year":"","journal-title":"Sci. Rep."},{"key":"B34","doi-asserted-by":"publisher","first-page":"16305","DOI":"10.1038\/s41598-023-43571-3","article-title":"Diminishing of H. pylori adhesion to Cavia porcellus gastric epithelial cells by BCG vaccine mycobacteria","volume":"13","author":"Gonciarz","year":"","journal-title":"Sci. Rep"},{"key":"B35","doi-asserted-by":"publisher","first-page":"e0220636","DOI":"10.1371\/journal.pone.0220636","article-title":"The effect of Helicobacter pylori infection and different H. pylori components on the proliferation and apoptosis of gastric epithelial cells and fibroblasts","volume":"14","author":"Gonciarz","year":"2019","journal-title":"PLoS ONE"},{"key":"B36","doi-asserted-by":"publisher","first-page":"117193","DOI":"10.1016\/j.biopha.2024.117193","article-title":"M. bovis BCG reverses deleterious effects of H. pylori components towards gastric barrier cells in vitro","volume":"178","author":"Gonciarz","year":"","journal-title":"Biomed. Pharmacother"},{"key":"B37","doi-asserted-by":"publisher","first-page":"119126","DOI":"10.1016\/j.biopha.2026.119126","article-title":"Modulation of the gastrointestinal immune environment by chitosan microparticles loaded with Mycobacterium bovis BCG in a Cavia porcellus model in vivo, leading to reduced experimental H. pylori gastric colonization","volume":"196","author":"Gonciarz","year":"","journal-title":"Biomed. Pharmacother"},{"key":"B38","first-page":"185","article-title":"Anti-phagocytic activity of Helicobacter pylori lipopolysaccharide (LPS)-possible modulation of the innate immune response to these bacteria","volume":"57","author":"Grebowska","year":"2008","journal-title":"Pol. J. Microbiol"},{"key":"B39","doi-asserted-by":"publisher","first-page":"206","DOI":"10.1016\/j.actbio.2020.06.035","article-title":"Orally administrated chitosan microspheres bind Helicobacter pylori and decrease gastric infection in mice","volume":"114","author":"Henriques","year":"2020","journal-title":"Acta Biomater."},{"key":"B40","doi-asserted-by":"publisher","first-page":"1866","DOI":"10.3390\/antiox12101866","article-title":"The antioxidant curcumin solubilized as oil-in-water nanoemulsions or chitosan nanocapsules effectively reduces Helicobacter pylori growth, bacterial biofilm formation, gastric cell adhesion and internalization","volume":"12","author":"Hidalgo","year":"2023","journal-title":"Antioxidants"},{"key":"B41","doi-asserted-by":"publisher","first-page":"15619","DOI":"10.1038\/s41598-024-66339-9","article-title":"Human gastric microbiota analysis of refractory H. pylori infection","volume":"14","author":"Huang","year":"2024","journal-title":"Sci. Rep"},{"key":"B42","volume-title":"Schistosomes, Liver Flukes and Helicobacter Pylori. IARC Monogr. Eval. Carcinog. Risks Hum. 61","year":"1994"},{"key":"B43","doi-asserted-by":"publisher","first-page":"373","DOI":"10.1126\/science.279.5349.373","article-title":"Helicobacter pylori adhesin binding fucosylated histo-blood group antigens revealed by retagging","volume":"279","author":"Ilver","year":"1998","journal-title":"Science."},{"key":"B44","doi-asserted-by":"publisher","first-page":"7","DOI":"10.2478\/aite-2025-0007","article-title":"Immunomodulatory effect of the Bacillus Calmette-Guerin (BCG) vaccine on the in vitro interferon response induced by respiratory syncytial virus (RSV) and severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) antigens","volume":"73","author":"Jurczak","year":"2025","journal-title":"AITE"},{"key":"B45","doi-asserted-by":"publisher","first-page":"e17084","DOI":"10.15252\/emmm.202217084","article-title":"Subcutaneous BCG vaccination protects against streptococcal pneumonia via regulating innate immune responses in the lung","volume":"15","author":"Kang","year":"2023","journal-title":"EMBO Mol. Med."},{"key":"B46","doi-asserted-by":"publisher","first-page":"1083330","DOI":"10.3389\/fmicb.2023.1083330","article-title":"Amoxicillin-docosahexaenoic acid encapsulated chitosan-alginate nanoparticles as a delivery system with enhanced biocidal activities against Helicobacter pylori and improved ulcer healing","volume":"14","author":"Khoshnood","year":"2023","journal-title":"Front. Microbiol."},{"key":"B47","doi-asserted-by":"publisher","first-page":"17537","DOI":"10.1073\/pnas.1202870109","article-title":"Bacille Calmette-Guerin induces NOD2-dependent nonspecific protection from reinfection via epigenetic reprogramming of monocytes","volume":"109","author":"Kleinnijenhuis","year":"2012","journal-title":"Proc. Natl. Acad. Sci. U.S.A"},{"key":"B48","doi-asserted-by":"publisher","first-page":"2120747","DOI":"10.1080\/19490976.2022.2120747","article-title":"Biomaterials for H. pylori therapy: therapeutic potential and future perspectives","volume":"14","author":"Lai","year":"2022","journal-title":"Gut Microbes"},{"key":"B49","doi-asserted-by":"publisher","first-page":"3332","DOI":"10.1016\/j.biomaterials.2009.02.036","article-title":"Development of pH-responsive chitosan\/heparin nanoparticles for stomach-specific anti-Helicobacter pylori therapy","volume":"30","author":"Lin","year":"2009","journal-title":"Biomaterials"},{"key":"B50","doi-asserted-by":"publisher","first-page":"57","DOI":"10.2217\/nnm.14.76","article-title":"Berberine-loaded targeted nanoparticles as specific H. pylori eradication therapy: in vitro and in vivo study","volume":"10","author":"Lin","year":"2015","journal-title":"Nanomedicine"},{"key":"B51","doi-asserted-by":"publisher","first-page":"4466","DOI":"10.1016\/j.biomaterials.2013.02.028","article-title":"Genipin-cross-linked fucose-chitosan\/heparin nanoparticles for the eradication of Helicobacter pylori","volume":"34","author":"Lin","year":"2013","journal-title":"Biomaterials"},{"key":"B52","doi-asserted-by":"publisher","first-page":"1587","DOI":"10.1163\/092050609X12464345137685","article-title":"Preparation and evaluation of anti-Helicobacter pylori efficacy of chitosan nanoparticles in vitro and in vivo","volume":"20","author":"Luo","year":"2009","journal-title":"J. Biomater. Sci. Polym. Ed."},{"key":"B53","doi-asserted-by":"publisher","first-page":"573","DOI":"10.1126\/science.1069076","article-title":"Helicobacter pylori SabA adhesin in persistent infection and chronic inflammation","volume":"297","author":"Mahdavi","year":"2002","journal-title":"Science."},{"key":"B54","doi-asserted-by":"publisher","first-page":"1724","DOI":"10.1136\/gutjnl-2022-327745","article-title":"Management of Helicobacter pylori infection: the Maastricht VI\/Florence consensus report","volume":"71","author":"Malfertheiner","year":"2022","journal-title":"Gut"},{"key":"B55","doi-asserted-by":"publisher","first-page":"9652","DOI":"10.3390\/ijms22179652","article-title":"Advances in chitosan-based nanoparticles for drug delivery","volume":"22","author":"Miku\u0161ov\u00e1","year":"2021","journal-title":"Int. J. Mol. Sci."},{"key":"B56","doi-asserted-by":"publisher","first-page":"e938","DOI":"10.1093\/cid\/ciac182","article-title":"Efficacy of BCG vaccination against respiratory tract infections in older adults during the coronavirus disease 2019 pandemic","volume":"75","author":"Moorlag","year":"2022","journal-title":"Clin. Infect. Dis."},{"key":"B57","doi-asserted-by":"publisher","first-page":"44","DOI":"10.1007\/s10856-023-06748-w","article-title":"Targeted delivery of a short antimicrobial peptide (CM11) against Helicobacter pylori gastric infection using concanavalin A-coated chitosan nanoparticles","volume":"34","author":"Moosazadeh Moghaddam","year":"2023","journal-title":"J. Mater. Sci. Mater. Med."},{"key":"B58","doi-asserted-by":"publisher","first-page":"180","DOI":"10.1016\/S0022-5347(17)58737-6","article-title":"Intracavitary Bacillus Calmette-Guerin in the treatment of superficial bladder tumors","volume":"116","author":"Morales","year":"1976","journal-title":"J. Urol."},{"key":"B59","doi-asserted-by":"publisher","first-page":"375","DOI":"10.1038\/s41577-020-0285-6","article-title":"Defining trained immunity and its role in health and disease","volume":"20","author":"Netea","year":"2020","journal-title":"Nat. Rev. Immunol."},{"key":"B60","doi-asserted-by":"publisher","first-page":"aaf1098","DOI":"10.1126\/science.aaf1098","article-title":"Trained immunity: a program of innate immune memory in health and disease","volume":"352","author":"Netea","year":"2016","journal-title":"Science"},{"key":"B61","doi-asserted-by":"publisher","first-page":"136","DOI":"10.1006\/cimm.2000.1654","article-title":"Potential role of CagA in the inhibition of T cell reactivity in Helicobacter pylori infections","volume":"202","author":"Paziak-Doma\u0144ska","year":"2000","journal-title":"Cell. Immunol."},{"key":"B62","doi-asserted-by":"publisher","first-page":"487","DOI":"10.1002\/ijc.28999","article-title":"Global burden of gastric cancer attributable to Helicobacter pylori","volume":"136","author":"Plummer","year":"2015","journal-title":"Int. J. Canc."},{"key":"B63","doi-asserted-by":"publisher","first-page":"2098","DOI":"10.1007\/s12247-023-09776-9","article-title":"Mucoadhesive (type-I) and floating (type-II) chitosan beads for improved gastric retention of clarithromycin","volume":"18","author":"Rehman","year":"2023","journal-title":"J. Pharm. Innov."},{"key":"B64","doi-asserted-by":"publisher","first-page":"558349","DOI":"10.3389\/fbioe.2020.558349","article-title":"Chitosan nanoparticle-based mucosal vaccines against infectious diseases","volume":"8","author":"Renu","year":"2020","journal-title":"Front. Bioeng. Biotechnol"},{"key":"B65","doi-asserted-by":"publisher","first-page":"127","DOI":"10.1177\/1753425913518225","article-title":"Helicobacter pylori-driven modulation of NK cell expansion, intracellular cytokine expression and cytotoxic activity","volume":"21","author":"Rudnicka","year":"2015","journal-title":"Innate Immun."},{"key":"B66","doi-asserted-by":"publisher","first-page":"1561","DOI":"10.1136\/gutjnl-2025-335523","article-title":"Helicobacter pylori antibiotic resistance: a global challenge in search of solutions","volume":"74","author":"Schulz","year":"2025","journal-title":"Gut"},{"key":"B67","doi-asserted-by":"publisher","first-page":"14559","DOI":"10.1073\/pnas.96.25.14559","article-title":"Altered states: involvement of phosphorylated CagA in the induction of host cellular growth changes by Helicobacter pylori","volume":"96","author":"Segal","year":"1999","journal-title":"Proc. Natl. Acad. Sci. U.S.A"},{"key":"B68","doi-asserted-by":"publisher","first-page":"114280","DOI":"10.1016\/j.ejpb.2024.114280","article-title":"Engineering resveratrol-loaded chitosan nanoparticles for potential use against Helicobacter pylori infection","volume":"199","author":"Sp\u00f3sito","year":"2024","journal-title":"Eur. J. Pharm. Biopharm."},{"key":"B69","doi-asserted-by":"publisher","first-page":"1603732","DOI":"10.3389\/fped.2025.1603732","article-title":"BCG vaccination: historical role, modern applications, and future perspectives in tuberculosis and beyond","volume":"13","author":"Starshinova","year":"2025","journal-title":"Front. Pediatr"},{"key":"B70","doi-asserted-by":"publisher","first-page":"6699913","DOI":"10.1155\/ijbm\/6699913","article-title":"Therapeutic effect of eugenol-loaded chitosan nanoparticles against Helicobacter pylori infection: a histologic and molecular study","volume":"2026","author":"Tahmasebi","year":"2026","journal-title":"Int. J. Biomater."},{"key":"B71","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1016\/j.vaccine.2018.03.009","article-title":"BCG vaccines: WHO position paper - February 2018","volume":"93","year":"2018","journal-title":"Wkly. Epidemiol. Rec."},{"key":"B72","unstructured":"Contraindications for BCG. WHO TB Knowledge Sharing Platform\n          \n          2024"},{"key":"B73","doi-asserted-by":"publisher","first-page":"2994","DOI":"10.3390\/polym14152994","article-title":"Molecular docking and efficacy of Aloe vera gel based on chitosan nanoparticles against Helicobacter pylori and its antioxidant and anti-inflammatory activities","volume":"14","author":"Yahya","year":"2022","journal-title":"Polymers."},{"key":"B74","doi-asserted-by":"publisher","first-page":"1841","DOI":"10.1080\/21645515.2019.1706930","article-title":"BCG: a vaccine with multiple faces","volume":"16","author":"Yamazaki-Nakashimada","year":"2020","journal-title":"Hum. Vaccin. Immunother."},{"key":"B75","doi-asserted-by":"publisher","first-page":"2117","DOI":"10.3390\/pharmaceutics14102117","article-title":"Retention time extended by nanoparticles improves the eradication of highly antibiotic-resistant Helicobacter pylori","volume":"14","author":"Yao","year":"2022","journal-title":"Pharmaceutics"},{"key":"B76","doi-asserted-by":"publisher","first-page":"e13103","DOI":"10.1111\/hel.13103","article-title":"Global primary antibiotic resistance rate of Helicobacter pylori in recent 10 years: a systematic review and meta-analysis","volume":"29","author":"Yu","year":"2024","journal-title":"Helicobacter"},{"key":"B77","doi-asserted-by":"publisher","first-page":"123849","DOI":"10.1016\/j.carbpol.2025.123849","article-title":"Carboxymethyl chitosan and poly-gamma-glutamic acid-based gastroretentive sponge with high swelling and mechanical stability for targeted eradication of Helicobacter pylori","volume":"366","author":"Zhang","year":"2025","journal-title":"Carbohydr. Polym."}],"container-title":["Frontiers in Microbiology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fmicb.2026.1937380\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,9]],"date-time":"2026-09-09T15:17:24Z","timestamp":1788967044000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fmicb.2026.1937380\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9,9]]},"references-count":77,"alternative-id":["10.3389\/fmicb.2026.1937380"],"URL":"https:\/\/doi.org\/10.3389\/fmicb.2026.1937380","relation":{},"ISSN":["1664-302X"],"issn-type":[{"value":"1664-302X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,9,9]]},"article-number":"1937380"}}